Cite

HARVARD Citation

    Hoffmeister‐Wittmann, P. et al. (2022). Bcl‐xL as prognostic marker and potential therapeutic target in cholangiocarcinoma. Liver international. pp. 2855-2870. [Online]. 
  
Back to record